4/A//SEC Filing
Kashmolah Ghazi 4/A
Accession 0001209191-22-047309
CIK 0001652724other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 3:54 PM ET
Size
5.3 KB
Accession
0001209191-22-047309
Insider Transaction Report
Form 4/AAmended
Kashmolah Ghazi
Ex. VP &Chief Quality Officer
Transactions
- Sale
Common Stock
2022-08-17$2.52/sh−19,074$48,066→ 180,757 total
Footnotes (3)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.
- [F2]This amendment corrects the price of the shares sold, which was inadvertently incorrectly reported on the original Form 4.
- [F3]Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.
Documents
Issuer
Lucira Health, Inc.
CIK 0001652724
Entity typeother
Related Parties
1- filerCIK 0001877741
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 3:54 PM ET
- Size
- 5.3 KB